Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074224

« Back to Dashboard

NDA 074224 describes TRIAZOLAM, which is a drug marketed by Mylan Pharms Inc, Watson Labs, and West-ward Pharms Int, and is included in three NDAs. It is available from five suppliers. Additional details are available on the TRIAZOLAM profile page.

The generic ingredient in TRIAZOLAM is triazolam. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the triazolam profile page.

Summary for 074224

Formulation / Manufacturing:see details

Pharmacology for NDA: 074224


Medical Subject Heading (MeSH) Categories for 074224

Suppliers and Packaging for NDA: 074224

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAZOLAM triazolam TABLET;ORAL 074224 ANDA Rebel Distributors Corp 21695-284 21695-284-10 10 TABLET in 1 BOTTLE (21695-284-10)
TRIAZOLAM triazolam TABLET;ORAL 074224 ANDA Rebel Distributors Corp 21695-284 21695-284-00 100 TABLET in 1 BOTTLE (21695-284-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.125MG
Approval Date:Jun 1, 1994TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.25MG
Approval Date:Jun 1, 1994TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: